Effect on smoking quit rate of telling smokers their health risk appraisal in terms of health age: A randomized control trial

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 12, 2014, Pages 4963-4968

  Paek, Yu Jin ^a   Lee, Sungkyu ^b   Kim, Yun Hee ^c   Lee, Kang Sook ^d   Yim, Hyeon Woo ^d   Kim, Myung Shig ^e   Kim, Cheol Hwan ^f,g   Jeung, Ok ^h  

^a Hallym University   (South Korea)

^b Yonsei University   (South Korea)

^c Pukyong National University   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Jeonju University   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Seoul Cyber University   (South Korea)

^h NONE

Author keywords

Cessation; Counseling; Health risk appraisal; Nicotine dependence

Indexed keywords

CARBON MONOXIDE; COTININE;

ADULT; AGED; CONTROLLED STUDY; COUNSELING; FOLLOW UP; HEALTH STATUS INDICATOR; HUMAN; INTERVENTION STUDY; MALE; MIDDLE AGED; MOTIVATION; PREVENTION AND CONTROL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; TOBACCO DEPENDENCE; URINE;

ADULT; AGED; CARBON MONOXIDE; COTININE; COUNSELING; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; MOTIVATION; PROGNOSIS; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84904705457     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.12.4963     Document Type: Article

References (24)

1. Alexander G (2003). Health risk appraisal. Int Electron J Health Educ, 3, 133-7.
2. Audrain J, Boyd NR, Roth J, et al (1997). Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. J Addict Behav, 22, 741-51.
3. Bovet P, Perret F, Cornuz J, et al (2002). Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques. Prev Med, 34, 215-20.
4. Buffels J, Degryse J, Decramer M, et al (2005). Can spirometry improve the success rate of smoking cessation in general practice. Eur Respir J, 26, 670.
5. Buffels J, Degryse J, Decramer M, et al (2006). Spirometry and smoking cessation advice in general practice: a randomised clinical trial. Respir Med, 100, 2012-7.
6. Doll R, Peto R, Wheatley K, et al (1994). Mortality in relation to smoking: 40 years' observations on male british doctors. BMJ, 309, 901-11.
7. Fletcher DJ, Smith GL (1986). Health-risk appraisal. helping patients predict and prevent health problems. Postgrad Med, 80, 69-71.
8. Ito H, Matsuo K, Wakai K, et al (2006). An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Prev Med, 42, 102-8.
9. Jayakirshnan R, Uutela A, Mathew A, et al (2013) Smoking cessation intervention in rural Kerala, India; findings of a randomised controlled trial. Asian Pac J Cancer Prev, 14, 6797-802.
10. Karimy M, Niknami S, Heidarina AR, et al (2013). Refusal self efficacy, self esteem, smoking refusal skills and water pipe(hookah) smoking among Iranian male adoescents. Asian Pac J Cancer Prev, 14, 7283-8.
11. Kim J (2004). The predictive accuracy of health risk appraisal in Korean males: using national health insuarance incorporation program. MPH Thesis, Seoul National University.
12. Lerman C, Gold K, Audrain J, et al (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol, 16, 87.
13. Lin M, Huang S, Shih W, et al (2013). Effects of an anti-smoking program to prevent lung cancer among urban aboriginals in Taiwan. Asian Pac J Cancer Prev, 14, 6451-7.
14. Martin-Lujan F, Piñol-Moreso JL, Martin-Vergara N, et al (2011). Effectiveness of a structured motivational intervention including smoking cessation advice and spirometry information in the primary care setting: the ESPITAP study. BMC Public Health, 11, 859.
15. Oh J, Lim MK, Yun EH, et al (2013). Cost and effectiveness of the nationwide government-supported smoking cessation clinics in the republic of Korea. Tob Control, 22, 73-7.
16. Park J (2007). The development and validation of health risk appraisal (HRA) in Korean men and women. PhD Thesis, Seoul National University.
17. Parkes G, Greenhalgh T, Griffin M, et al (2008). Effect on smoking quit rate of telling patients their lung age: the step2quit randomised controlled trial. BMJ, 336, 598-600.
18. Risser NL, Belcher DW (1990). Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling. J Gen Intern Med, 5, 16-22.
19. Robbins L, Blankenbaker R (1982). Prospective Medicine And The Health Hazard Appraisal. Norwalk: Appleton-Century-Crofts.
20. Robbins L, Hall J (1970). How To Practice Prospective Medicine. Methodist Hospital of Indiana: Indianappolis.
21. Rodondi N, Collet T, Nanchen D, et al (2012). Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial. Arch Intern Med, 172, 344.
22. Sadusk Jr JF, Robbins LC (1968). Proposal for health-hazard appraisal in comprehensive health care. JAMA, 203, 1108-12.
23. Stead LF, Perera R, Bullen C, et al (2008). Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 1, CD000146.
24. Wilt TJ, Niewoehner D, Kane RL, et al (2007). Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res, 9, 21-32.